Tissue expression of the proteins fas and fas ligand in colorectal cancer and liver metastases (Q83308533)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21271302%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Tissue expression of the proteins fas and fas ligand in colorectal cancer and liver metastases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21271302%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21271302%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Maria Lambropoulou

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21271302%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Spuridon Mathaiou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21271302%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Anastasios J Karayiannakis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21271302%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Dimitris Patsouras

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21271302%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Constantinos Simopoulos

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21271302%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

1 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21271302%20AND%20SRC:MED&resulttype=core&format=json

Journal of gastrointestinal cancer

21 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21271302%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21271302%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21271302%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

224-228

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21271302%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12029-011-9252-6

21 January 2020

exact match

0 references

cites work

Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18.

1 reference

12 December 2020

Fas—Beyond Death: A regenerative role for Fas in the nervous system

1 reference

12 December 2020

c-FLIP expression in colorectal carcinomas: association with Fas/FasL expression and prognostic implications.

1 reference

12 December 2020

Changes in apoptosis during the development of colorectal cancer: a systematic review of the literature

1 reference

12 December 2020

Fas (CD95/APO-1) and Fas ligand expression in normal pancreas and pancreatic tumors. Implications for immune privilege and immune escape.

1 reference

12 December 2020

Expression of Fas (CD95/APO-1) ligand by human breast cancers: significance for tumor immune privilege

1 reference

12 December 2020

Apoptosis in neural development and disease

1 reference

12 December 2020

Fas ligand is up-regulated during the colorectal adenoma-carcinoma sequence

1 reference

12 December 2020

Prognostic impact of Fas ligand on hepatocellular carcinoma after hepatectomy.

1 reference

12 December 2020

Human urinary bladder transitional cell carcinomas acquire the functional Fas ligand during tumor progression.

1 reference

12 December 2020

Fas ligand upregulation is an early event in colonic carcinogenesis

1 reference

12 December 2020

Combination of human Fas (CD95/Apo-1) ligand with adriamycin significantly enhances the efficacy of antitumor response

1 reference

12 December 2020

FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas

1 reference

12 December 2020

Prognostic significance of Fas and Fas ligand system-associated apoptosis in gastric cancer.

1 reference

12 December 2020

Resistance to Fas (APO-1/CD95)-mediated apoptosis and expression of Fas ligand in esophageal cancer: the Fas counterattack

1 reference

12 December 2020

The "Fas counterattack" is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instability.

1 reference

12 December 2020

Significance of Fas receptor protein expression in epithelial ovarian cancer.

1 reference

12 December 2020

Close association between Fas ligand (FasL; CD95L)-positive tumor-associated macrophages and apoptotic cancer cells along invasive margin of colorectal carcinoma: a proposal on tumor-host interactions.

1 reference

12 December 2020

Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance

1 reference

12 December 2020

Differential expression of cell cycle and apoptosis related proteins in colorectal mucosa, primary colon tumours, and liver metastases

1 reference

12 December 2020

10.1007/S12029-011-9252-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21271302%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference